Intra-articular corticoid injection induces circulating glucocorticoid bioactivity and systemic immune activation in juvenile idiopathic arthritis

References

• Lahdenne P, Vahasalo P, Honkanen V. Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study. Ann Rheum Dis 2003;62:245–7.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet 2007;370:1861–74.
   PubMed Web of Science ®Google Scholar
• Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, . International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390–2.
   PubMed Web of Science ®Google Scholar
• Cleary AG, Murphy HD, Davidson JE. Intra-articular corticosteroid injections in juvenile idiopathic arthritis. Arch Dis Child 2003;88:192–6.
   PubMed Web of Science ®Google Scholar
• Wallen M, Gillies D. Intra-articular steroids and splints/rest for children with juvenile idiopathic arthritis and adults with rheumatoid arthritis. Cochrane Database Syst Rev 2006;(1):CD002824.
   Google Scholar
• Bloom BJ, Alario AJ, Miller LC. Intra-articular corticosteroid therapy for juvenile idiopathic arthritis: report of an experiential cohort and literature review. Rheumatol Int 2010. Published online: 14 February. doi:10.1007/s00296-010-1365–x.
   Google Scholar
• Honkanen VEA, Rautonen JK, Pelkonen PM. Intra-articular glucocorticoids in early juvenile chronic arthritis. Acta Paediatr 1993;82:1072–4.
   PubMed Web of Science ®Google Scholar
• Zulian F, Martini G, Gobber D, Agosto C, Gigante C, Zacchello F. Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis. Rheumatology 2003;42:1254–9.
   PubMed Web of Science ®Google Scholar
• Zulian F, Martini G, Gobber D, Plebani M, Zacchello F, Manners P. Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial. Rheumatology 2004;43:1288–91.
   PubMed Web of Science ®Google Scholar
• Padeh S, Passwell JH. Intraarticular corticosteroid injection in the management of children with chronic arthritis. Arthritis Rheum 1998;41:1210–14.
   PubMedGoogle Scholar
• Hollander JL, Brown EM, Jessar RA, Brown CY. Hydrocortisone and cortisone injected into arthritis joints: comparative effects of and use of hydrocortisone as a local antiarthritic agent. J Am Med Assoc 1951;147:1629–35.
   PubMed Web of Science ®Google Scholar
• Huppertz HI, Pfuller H. Transient suppression of endogenous cortisol production after intraarticular steroid therapy for chronic arthritis in children. J Rheumatol 1997;24:1833–7.
   PubMed Web of Science ®Google Scholar
• Kumar S, Singh RJ, Reed AM, Lteif AN. Cushing’s syndrome after intra-articular and intradermal administration of triamcinolone acetonide in three pediatric patients. Pediatrics 2004;113:1820–4.
   PubMed Web of Science ®Google Scholar
• Hamalainen H, Arkela-Kautiainen M, Kautiainen H, Haapasaari J, Leirisalo-Repo M. Bone mineral content in young adults with active or inactive juvenile idiopathic arthritis and in controls. Scand J Rheumatol 2010;39:219–22.
   PubMed Web of Science ®Google Scholar
• Raivio T, Palvimo JJ, Kannisto S, Voutilainen R, Janne OA. Transactivation assay for determination of glucocorticoid bioactivity in human serum. J Clin Endocrinol Metab 2002;87:3740–4.
   PubMed Web of Science ®Google Scholar
• Vihinen MK, Raivio T, Verkasalo M, Janne OA, Kolho K-L. Circulating glucocorticoid bioactivity during peroral glucocorticoid treatment in children and adolescents with inflammatory bowel disease. J Clin Gastroenterol 2008;42:1017–24.
   PubMed Web of Science ®Google Scholar
• Rintamaki H, Salo HM, Vaarala O, Kolho KL. New means to monitor the effect of glucocorticoid therapy in children. World J Gastroenterol 2010;16:1104–9.
   PubMed Web of Science ®Google Scholar
• Rintamaki H, Sipponen T, Salo HM, Vaarala O, Kolho K-L. Serum immune-activation potency and response to anti-TNF-alpha therapy in Crohn’s disease. World J Gastroenterol 2010;16:5845–51.
   PubMed Web of Science ®Google Scholar
• Berntson L, Svensson E. Pain assessment in children with juvenile chronic arthritis: a matter of scaling and rater. Acta Paediatr 2001;90:1131–6.
   PubMed Web of Science ®Google Scholar
• van Dijk M, Koot HM, Saad HH, Tibboel D, Passchier J. Observational visual analog scale in pediatric pain assessment: useful tool or good riddance? Clin J Pain 2002;18:310–16.
   PubMed Web of Science ®Google Scholar
• Dempster H, Porepa M, Young N, Feldman BM. The clinical meaning of functional outcome scores in children with juvenile arthritis. Arthritis Rheum 2001;44:1768–74.
   PubMedGoogle Scholar
• Pelkonen P, Ruperto N, Honkanen V, Hannula S, Savolainen A, Lahdenne P. The Finnish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001;19:S55–9.
   PubMed Web of Science ®Google Scholar
• Romagnani S. Th1/Th2 cells. Inflamm Bowel Dis 1999;5:285–94.
   PubMed Web of Science ®Google Scholar
• Halminen M, Klemetti P, Vaarala O, Hurme M, Ilonen J. Interferon-gamma production in antigen specific T cell response: quantitation of specific mRNA and secreted protein. Scand J Immunol 1997;46:388–92.
   PubMed Web of Science ®Google Scholar
• Honkanen J, Skarsvik S, Knip M, Vaarala O. Poor in vitro induction of FOXP3 and ICOS in type 1 cytokine environment activated T-cells from children with type 1 diabetes. Diabetes Metab Res Rev 2008;24:635–41.
   PubMed Web of Science ®Google Scholar
• Armstrong RD, English J, Gibson T, Chakraborty J, Marks V. Serum methylprednisolone levels following intra-articular injection of methylprednisolone acetate. Ann Rheum Dis 1981;40:571–4.
   PubMed Web of Science ®Google Scholar
• Middleton J, Americh L, Gayon R, Julien D, Aguilar L, Amalric F, . Endothelial cell phenotypes in the rheumatoid synovium: activated, angiogenic, apoptotic and leaky. Arthritis Res Ther 2004;6:60–72.
   PubMed Web of Science ®Google Scholar
• Boumpas DT, Paliogianni F, Anastassiou ED, Balow JE. Glucocorticosteroid action on the immune system: molecular and cellular aspects. Clin Exp Rheumatol 1991;9:413–23.
   PubMed Web of Science ®Google Scholar
• Franchimont D, Galon J, Gadina M, Visconti R, Zhou Y, Aringer M, . Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J Immunol 2000;164:1768–74.
   PubMed Web of Science ®Google Scholar
• Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M, . Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002;16:61–71.
   PubMed Web of Science ®Google Scholar
• Ramirez F, Fowell DJ, Puklavec M, Simmonds S, Mason D. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J Immunol 1996;156:2406–12.
   PubMed Web of Science ®Google Scholar
• Blotta MH, DeKruyff RH, Umetsu DT. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J Immunol 1997;158:5589–95.
   PubMed Web of Science ®Google Scholar
• DeKruyff RH, Fang Y, Umetsu DT. Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production. J Immunol 1998;160:2231–7.
   PubMed Web of Science ®Google Scholar